glp-1 side effect management Dietitians boost therapy success with personalized care and GLP-1 medications, commonly used for

It names adults with a BMI of 30 or above, adults at 27 or above with weight-related conditions, and people with type 2 diabetes

However, the FDA label explicitly states that "it is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of GLP-1 receptor agonist-induced rodent thyroid C-cell tumors has not been determined." The rodent thyroid has substantially more C-cells than the human thyroid, and rodents may be more susceptible to this effect

While GEP-44 remains in preclinical development, these early findings position SureNano Science within a highly strategic segment of the obesity treatment landscape

Safety and Considerations for Using Ozempic in PCOS While Ozempic shows promise for managing PCOS-related insulin resistance and weight, it is not officially approved for PCOS treatment by regulatory agencies